SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Actinium Pharmaceuticals, Inc. – ‘8-K’ for 4/11/13 – EX-3.1

On:  Wednesday, 4/17/13, at 5:14pm ET   ·   For:  4/11/13   ·   Accession #:  1213900-13-1911   ·   File #:  0-52446

Previous ‘8-K’:  ‘8-K’ on 3/14/13 for 3/9/13   ·   Next:  ‘8-K’ on / for 5/31/13   ·   Latest:  ‘8-K’ on 12/1/23 for 11/30/23   ·   21 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/17/13  Actinium Pharmaceuticals, Inc.    8-K:5,9     4/11/13    6:1.9M                                   Edgar Agents LLC/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     21K 
 2: EX-3.1      Delaware Certificate of Incorporation for Actinium  HTML      6K 
                          Pharmaceuticals, Inc.                                  
 3: EX-3.2      Bylaws for Actinium Pharmaceuticals, Inc.           HTML     65K 
 4: EX-3.3      Delaware Certificate of Merger                      HTML      4K 
 5: EX-3.4      Nevada Articles of Merger                           HTML     12K 
 6: EX-99.1     Press Release Dated April 17, 2013                  HTML     14K 


EX-3.1   —   Delaware Certificate of Incorporation for Actinium Pharmaceuticals, Inc.


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 3.1
 
 
 
 

 
 
 
 
 

 
 
 
 


21 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/26/24  Actinium Pharmaceuticals, Inc.    10-Q        3/31/24   49:10M                                    EdgarAgents LLC/FA
 3/29/24  Actinium Pharmaceuticals, Inc.    S-8         3/29/24    4:57K                                    EdgarAgents LLC/FA
 3/29/24  Actinium Pharmaceuticals, Inc.    10-K       12/31/23   65:17M                                    EdgarAgents LLC/FA
 2/02/24  Actinium Pharmaceuticals, Inc.    S-3/A                  3:589K                                   EdgarAgents LLC/FA
11/02/23  Actinium Pharmaceuticals, Inc.    10-Q        9/30/23   46:4.2M                                   EdgarAgents LLC/FA
 8/14/23  Actinium Pharmaceuticals, Inc.    10-Q        6/30/23   45:4M                                     EdgarAgents LLC/FA
 8/11/23  Actinium Pharmaceuticals, Inc.    S-3                    4:540K                                   EdgarAgents LLC/FA
 5/15/23  Actinium Pharmaceuticals, Inc.    10-Q        3/31/23   47:5.9M                                   EdgarAgents LLC/FA
 3/31/23  Actinium Pharmaceuticals, Inc.    10-K       12/31/22   60:8.1M                                   EdgarAgents LLC/FA
11/14/22  Actinium Pharmaceuticals, Inc.    10-Q        9/30/22   47:3.4M                                   EdgarAgents LLC/FA
 8/19/22  Actinium Pharmaceuticals, Inc.    S-8         8/19/22    5:185K                                   EdgarAgents LLC/FA
 8/12/22  Actinium Pharmaceuticals, Inc.    10-Q        6/30/22   48:3.7M                                   EdgarAgents LLC/FA
 5/13/22  Actinium Pharmaceuticals, Inc.    10-Q        3/31/22   44:2.7M                                   EdgarAgents LLC/FA
 3/25/22  Actinium Pharmaceuticals, Inc.    10-K       12/31/21   56:4.2M                                   EdgarAgents LLC/FA
11/12/21  Actinium Pharmaceuticals, Inc.    10-Q        9/30/21   42:3.1M                                   EdgarAgents LLC/FA
 7/30/21  Actinium Pharmaceuticals, Inc.    10-Q        6/30/21   44:3.2M                                   EdgarAgents LLC/FA
 5/14/21  Actinium Pharmaceuticals, Inc.    10-Q        3/31/21   43:2.3M                                   EdgarAgents LLC/FA
 3/31/21  Actinium Pharmaceuticals, Inc.    10-K       12/31/20   56:3.5M                                   EdgarAgents LLC/FA
10/23/20  Actinium Pharmaceuticals, Inc.    10-Q        9/30/20   41:2.6M                                   EdgarAgents LLC/FA
 8/14/20  Actinium Pharmaceuticals, Inc.    10-Q        6/30/20   44:2.8M                                   EdgarAgents LLC/FA
 8/07/20  Actinium Pharmaceuticals, Inc.    S-3                    4:702K                                   EdgarAgents LLC/FA
Top
Filing Submission 0001213900-13-001911   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 12:26:54.3am ET